Explore: Drug Discovery · Biotech · Diagnostics · Medtech · Pre-Seed · Seed · Series A
Elanco Ventures
Elanco Animal Health
Corporate VC$25MCo-investsLeads rounds
Investment Thesis
Support and advance innovation in animal health through strategic investments in therapeutic advancements and supportive technologies.
About Elanco Ventures
Elanco Ventures is Elanco Animal Health’s corporate venture capital platform focused on early-stage animal health innovation, with an announced $25 million multi-year commitment and a planned launch in late 2026. It targets Pre-Seed, Seed, and Series A companies working on therapeutic advancements and enabling technologies for animal care.
Sectors
Drug DiscoveryBiotechDiagnosticsMedtechHealthtech Infrastructure
Stages
pre-seedseedSeries A
Geographic focus
United States
Notable Investments
AgTech Accelerator
Verified 22 June 2026 · Sources: company website, Fusion42 review
Frequently asked questions
- What does Elanco Ventures invest in?
- Elanco Ventures invests in Drug Discovery, Biotech, Diagnostics, Medtech and Healthtech Infrastructure at the pre-seed, seed and series-a stages.
- Which geographies does Elanco Ventures focus on?
- Elanco Ventures focuses on United States, and is headquartered in United States.